TherOx, Inc., a privately held medical device company focused on the treatment of Acute Myocardial Infarction (AMI), announced that data will be presented on its next-generation Supersaturated Oxygen (SSO2) Therapy at the upcoming 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.
Help employers find you! Check out all the jobs and post your resume.
